Non-Small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ): Measurement Properties and Estimated Clinically Meaningful Thresholds From a Phase 3 Study

Non-Small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ): Measurement Properties and Estimated Clinically Meaningful Thresholds From a Phase 3 Study

Introduction: The NSCLC Symptom Assessment Questionnaire (NSCLC-SAQ) was developed to assess NSCLC symptom severity in accordance with Food and Drug Administration evidentiary expectations leading to Food and Drug Administration qualification in 2018. This study evaluated the NSCLC-SAQ’s measurement...

Full description

Bibliographic Details
Main Authors: Paul Williams, MPH, Thomas Burke, PharmD, PhD, Josephine M. Norquist, MS, Christina Daskalopoulou, PhD, Rebecca M. Speck, PhD, MPH, Ayman Samkari, MD, Sonya Eremenco, MA, Stephen Joel Coons, PhD
Format: Article
Language:English
Published: Elsevier 2022-04-01
Series:JTO Clinical and Research Reports
Subjects:
Patient-reported outcome
Non–small cell lung carcinoma
Psychometric properties
Symptom assessment
Clinically meaningful within-person change
Online Access:http://www.sciencedirect.com/science/article/pii/S2666364322000224

Internet

http://www.sciencedirect.com/science/article/pii/S2666364322000224

Similar Items